ElectroCore seeks partners to push forward noninvasive VNS device for headaches
This article was originally published in Clinica
A US company that has developed a noninvasive vagus nerve stimulation (nVNS) device for treating, as well as preventing, cluster and migraine headaches is looking for investors and partners to support its clinical and commercialisation plans.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.